Predictors of clinical efficacy of ‘Ablate and Pace’ therapy in patients with permanent atrial fibrillation

Abstract

In patients affected by severely symptomatic permanent AF, Ablate and Pace therapy yielded a clinical benefit in 63% of RV-paced patients and 83% of CRT-paced patients. CRT pacing and echo-optimised CRT were the only independent predictor of clinical benefit.